Symbols / ASPI Stock $5.35 -1.47% ASP Isotopes Inc.

Basic Materials • Chemicals • United States • NCM
ASPI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Basic Materials
Industry Chemicals
CEO Mr. Paul Elliot Mann C.F.A.
Exch · Country NCM · United States
Market Cap 673.58M
Enterprise Value 613.68M
Income -175.09M
Sales 23.85M
FCF (ttm) -74.90M
Book/sh 1.83
Cash/sh 2.66
Employees 271
Insider 10d —
IPO Nov 10, 2022
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -5.11
PEG —
P/S 28.24
P/B 2.93
P/C —
EV/EBITDA -10.98
EV/Sales 25.73
Quick Ratio 10.84
Current Ratio 12.23
Debt/Eq 82.15
LT Debt/Eq —
EPS (ttm) -2.11
EPS next Y -1.05
EPS Growth —
Revenue Growth 12.96%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-15
Earnings (prior) 2026-04-10
ROA -12.07%
ROE -101.79%
ROIC —
Gross Margin 14.28%
Oper. Margin -133.88%
Profit Margin 0.00%
Shs Outstand 125.90M
Shs Float 100.40M
Insider Own 13.02%
Instit Own 58.43%
Short Float 23.03%
Short Ratio 5.20
Short Interest 25.33M
52W High 14.49
vs 52W High -63.08%
52W Low 3.92
vs 52W Low 36.48%
Beta 3.61
Impl. Vol. 1.29%
Rel Volume 0.60
Avg Volume 4.78M
Volume 2.88M
Target (mean) $13.00
Tgt Median $13.00
Tgt Low $11.00
Tgt High $15.00
# Analysts 3
Recom Strong_buy
Prev Close $5.43
Price $5.35
Change -1.47%
About

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$13.00
Mean price target
2. Current target
$5.35
Latest analyst target
3. DCF / Fair value
$-10.71
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.35
Low
$11.00
High
$15.00
Mean
$13.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-14 main Canaccord Genuity Buy → Buy $11
2025-12-04 init Cantor Fitzgerald — → Overweight $13
2025-11-24 main Canaccord Genuity Buy → Buy $11
2025-09-17 main Canaccord Genuity Buy → Buy $11
2025-05-21 main Canaccord Genuity Buy → Buy $11
2024-10-18 main Canaccord Genuity Buy → Buy $5
2024-10-04 init Canaccord Genuity — → Buy $5
2024-08-07 main HC Wainwright & Co. Buy → Buy $5
2024-04-17 main HC Wainwright & Co. Buy → Buy $6
2024-02-29 main HC Wainwright & Co. Buy → Buy $5
2023-12-05 init HC Wainwright & Co. — → Buy $3
News
RSS: Latest ASPI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-16 MOORE DUNCAN Director — 11,642 $5.20 $60,597
2026-04-16 AINSCOW ROBERT Chief Operating Officer — 22,500 $5.20 $117,112
2026-04-15 KIESSLING HEATHER Chief Financial Officer — 23,124 $5.48 $126,673
2026-03-06 AINSCOW ROBERT Chief Operating Officer — 8,438 $5.44 $45,894
2026-03-06 AINSCOW ROBERT Chief Operating Officer — 25,000 $4.51 $112,775
2026-03-02 MANN PAUL ELLIOT Officer — 162,153 $5.44 $881,464
2025-12-18 WIDER TODD Director — 36,548 $0.00 $0
2025-12-18 MOORE DUNCAN Director — 62,017 $0.00 $0
2025-12-18 RYAN ROBERT JOHN ANDREW Director — 36,548 $0.00 $0
2025-12-18 GORLEY MICHAEL Director — 36,548 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
23.85
+475.51%
4.14
+856.99%
0.43
0.00
Operating Revenue
23.85
+475.51%
4.14
+856.99%
0.43
0.00
Cost Of Revenue
20.44
+703.30%
2.54
+765.48%
0.29
0.00
Reconciled Cost Of Revenue
20.44
+703.30%
2.54
+765.48%
0.29
0.00
Gross Profit
3.40
+112.95%
1.60
+1050.61%
0.14
0.00
Operating Expense
60.60
+116.78%
27.95
+72.75%
16.18
+217.33%
5.10
Research And Development
12.36
+293.69%
3.14
+310.55%
0.76
-39.96%
1.27
Selling General And Administration
48.24
+94.40%
24.81
+60.96%
15.42
+302.99%
3.83
General And Administrative Expense
48.24
+94.40%
24.81
+60.96%
15.42
+302.99%
3.83
Other Gand A
48.24
+94.40%
24.81
+60.96%
15.42
+302.99%
3.83
Total Expenses
81.04
+165.72%
30.50
+85.12%
16.48
+223.10%
5.10
Operating Income
-57.19
-117.01%
-26.35
-64.28%
-16.04
-214.61%
-5.10
Total Operating Income As Reported
-59.91
-127.32%
-26.35
-64.28%
-16.04
-214.61%
-5.10
EBITDA
-157.07
-397.35%
-31.58
-95.62%
-16.14
-226.47%
-4.95
Normalized EBITDA
-172.16
-443.90%
-31.65
-95.50%
-16.19
-217.72%
-5.10
Reconciled Depreciation
1.91
+305.94%
0.47
+1158.25%
0.04
0.00
EBIT
-158.99
-396.01%
-32.05
-98.08%
-16.18
-227.22%
-4.95
Total Unusual Items
15.08
+21444.29%
0.07
+53.00%
0.05
-69.60%
0.15
Total Unusual Items Excluding Goodwill
15.08
+21444.29%
0.07
+53.00%
0.05
-69.60%
0.15
Special Income Charges
-2.72
0.00
—
—
Other Special Charges
2.72
—
—
—
Net Income
-175.09
-441.51%
-32.33
-98.54%
-16.29
-229.34%
-4.95
Pretax Income
-159.56
-393.81%
-32.31
-98.23%
-16.30
-229.62%
-4.95
Net Non Operating Interest Income Expense
6.21
+534.83%
0.98
+994.28%
-0.11
-3336.93%
0.00
Interest Expense Non Operating
0.57
+122.01%
0.26
+118.48%
0.12
0.00
Net Interest Income
6.21
+534.83%
0.98
+994.28%
-0.11
-3336.93%
0.00
Interest Expense
0.57
+122.01%
0.26
+118.48%
0.12
0.00
Interest Income Non Operating
6.79
+448.47%
1.24
+13543.38%
0.01
+168.30%
0.00
Interest Income
6.79
+448.47%
1.24
+13543.38%
0.01
+168.30%
0.00
Other Income Expense
-108.58
-1465.30%
-6.94
-4562.37%
-0.15
-198.84%
0.15
Other Non Operating Income Expenses
-123.67
-1664.89%
-7.01
-3501.83%
-0.19
-229.24%
0.15
Gain On Sale Of Security
17.80
+25325.71%
0.07
+53.00%
0.05
-69.60%
0.15
Tax Provision
0.28
+154.05%
0.11
+1909.88%
-0.01
0.00
Tax Rate For Calcs
0.00
+0.00%
0.00
+69900.00%
0.00
0.00
Tax Effect Of Unusual Items
3.17
+21444.29%
0.01
+106996.80%
0.00
0.00
Net Income Including Noncontrolling Interests
-159.84
-392.99%
-32.42
-98.99%
-16.29
-229.50%
-4.95
Net Income From Continuing Operation Net Minority Interest
-175.09
-441.51%
-32.33
-98.54%
-16.29
-229.34%
-4.95
Net Income From Continuing And Discontinued Operation
-175.09
-441.51%
-32.33
-98.54%
-16.29
-229.34%
-4.95
Net Income Continuous Operations
-159.84
-392.99%
-32.42
-98.99%
-16.29
-229.50%
-4.95
Minority Interests
-15.25
-17233.71%
0.09
+1027.72%
0.01
0.00
Normalized Income
-187.01
-477.37%
-32.39
-98.32%
-16.33
-220.51%
-5.10
Net Income Common Stockholders
-175.09
-398.64%
-35.11
-115.61%
-16.29
-229.34%
-4.95
Otherunder Preferred Stock Dividend
0.00
-100.00%
2.78
0.00
—
Diluted EPS
-2.11
-234.92%
-0.63
-28.57%
-0.49
-172.22%
-0.18
Basic EPS
-2.11
-234.92%
-0.63
-28.57%
-0.49
-172.22%
-0.18
Basic Average Shares
83.01
+49.11%
55.67
+68.36%
33.07
+23.41%
26.79
Diluted Average Shares
83.01
+49.11%
55.67
+68.36%
33.07
+23.41%
26.79
Diluted NI Availto Com Stockholders
-175.09
-398.64%
-35.11
-115.61%
-16.29
-229.34%
-4.95
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
498.02
+427.85%
94.35
+242.56%
27.54
+120.40%
12.50
Current Assets
399.92
+508.30%
65.74
+525.52%
10.51
+218.29%
3.30
Cash Cash Equivalents And Short Term Investments
333.31
+438.55%
61.89
+682.61%
7.91
+231.01%
2.39
Cash And Cash Equivalents
285.56
+361.40%
61.89
+682.61%
7.91
+231.01%
2.39
Cash Financial
—
—
7.91
+231.01%
2.39
Other Short Term Investments
47.74
—
—
—
Receivables
51.71
+2138.53%
2.31
+146.26%
0.94
0.00
Accounts Receivable
17.88
+2429.28%
0.71
+226.55%
0.22
0.00
Other Receivables
1.06
—
—
—
Taxes Receivable
0.76
-51.56%
1.57
—
—
Inventory
1.10
+1563.64%
0.07
0.00
—
Raw Materials
0.48
+633.33%
0.07
—
—
Work In Process
0.61
0.00
—
—
Finished Goods
0.00
0.00
—
—
Prepaid Assets
10.89
0.00
—
—
Current Deferred Assets
1.78
0.00
—
—
Other Current Assets
1.14
-23.21%
1.48
-11.18%
1.66
+82.26%
0.91
Total Non Current Assets
98.10
+242.96%
28.60
+67.95%
17.03
+85.25%
9.19
Net PPE
34.96
+48.94%
23.48
+96.10%
11.97
+32.22%
9.05
Gross PPE
37.96
+58.43%
23.96
+99.53%
12.01
+32.63%
9.05
Accumulated Depreciation
-3.00
-517.08%
-0.49
-1188.89%
-0.04
0.00
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
31.36
+258.28%
8.75
+440.31%
1.62
0.00
Construction In Progress
4.95
-64.57%
13.97
+53.37%
9.11
+11.08%
8.20
Other Properties
1.51
+34.76%
1.12
-10.86%
1.26
+47.41%
0.85
Leases
0.14
+18.10%
0.12
+440.89%
0.02
0.00
Goodwill And Other Intangible Assets
10.05
+217.17%
3.17
-3.03%
3.27
0.00
Goodwill
8.57
+170.52%
3.17
-3.03%
3.27
0.00
Other Intangible Assets
1.48
—
—
—
Investments And Advances
47.31
0.00
—
—
Long Term Equity Investment
1.33
0.00
—
—
Other Investments
45.98
0.00
—
—
Non Current Accounts Receivable
0.43
—
—
—
Non Current Deferred Assets
0.00
-100.00%
0.03
0.00
—
Non Current Deferred Taxes Assets
0.00
-100.00%
0.03
0.00
—
Other Non Current Assets
5.36
+177.85%
1.93
+7.53%
1.79
+1184.06%
0.14
Total Liabilities Net Minority Interest
235.12
+444.50%
43.18
+395.69%
8.71
+225.19%
2.68
Current Liabilities
32.70
+363.18%
7.06
+24.41%
5.67
+193.02%
1.94
Payables And Accrued Expenses
16.14
+389.57%
3.30
+36.07%
2.42
+41.19%
1.72
Payables
9.92
+871.30%
1.02
-8.17%
1.11
-17.94%
1.35
Accounts Payable
5.75
+463.66%
1.02
-8.17%
1.11
-17.94%
1.35
Current Accrued Expenses
6.22
+173.46%
2.28
+73.58%
1.31
+262.98%
0.36
Current Debt And Capital Lease Obligation
13.64
+740.17%
1.62
+86.79%
0.87
+989.44%
0.08
Current Debt
12.88
+1272.20%
0.94
+99.62%
0.47
+1289.48%
0.03
Other Current Borrowings
12.88
+1272.20%
0.94
+99.62%
0.47
+1289.48%
0.03
Current Capital Lease Obligation
0.75
+9.80%
0.68
+71.64%
0.40
+768.15%
0.05
Current Deferred Liabilities
0.88
+0.00%
0.88
+0.00%
0.88
0.00
Current Deferred Revenue
0.88
+0.00%
0.88
+0.00%
0.88
0.00
Other Current Liabilities
2.04
+62.05%
1.26
-16.20%
1.50
+967.96%
0.14
Total Non Current Liabilities Net Minority Interest
202.43
+460.40%
36.12
+1089.27%
3.04
+309.10%
0.74
Long Term Debt And Capital Lease Obligation
202.32
+460.11%
36.12
+2735.90%
1.27
+71.56%
0.74
Long Term Debt
200.79
+475.77%
34.87
—
—
Long Term Capital Lease Obligation
1.53
+22.60%
1.25
-2.02%
1.27
+71.56%
0.74
Non Current Deferred Liabilities
0.10
0.00
-100.00%
0.11
0.00
Non Current Deferred Taxes Liabilities
0.10
0.00
-100.00%
0.11
0.00
Other Non Current Liabilities
—
—
1.65
—
Stockholders Equity
204.15
+326.21%
47.90
+193.93%
16.30
+65.99%
9.82
Common Stock Equity
204.15
+326.21%
47.90
+193.93%
16.30
+65.99%
9.82
Capital Stock
1.12
+54.92%
0.72
+47.37%
0.49
+36.25%
0.36
Common Stock
1.12
+54.92%
0.72
+47.37%
0.49
+36.25%
0.36
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
111.68
+54.96%
72.07
+47.31%
48.92
+36.25%
35.91
Ordinary Shares Number
111.68
+54.96%
72.07
+47.31%
48.92
+36.25%
35.91
Additional Paid In Capital
431.76
+309.19%
105.52
+160.10%
40.57
+142.10%
16.76
Retained Earnings
-231.26
-311.70%
-56.17
-135.63%
-23.84
-215.62%
-7.55
Gains Losses Not Affecting Retained Earnings
2.54
+217.47%
-2.16
-134.97%
-0.92
-461.13%
0.26
Minority Interest
58.75
+1697.64%
3.27
+28.93%
2.53
0.00
Other Equity Adjustments
2.54
+217.47%
-2.16
-134.97%
-0.92
-461.13%
0.26
Total Equity Gross Minority Interest
262.90
+413.80%
51.17
+171.72%
18.83
+91.81%
9.82
Total Capitalization
404.94
+389.22%
82.77
+407.94%
16.30
+65.99%
9.82
Working Capital
367.22
+525.75%
58.69
+1113.43%
4.84
+254.10%
1.37
Invested Capital
417.83
+399.13%
83.71
+399.29%
16.77
+70.19%
9.85
Total Debt
215.96
+472.16%
37.74
+1661.61%
2.14
+160.60%
0.82
Capital Lease Obligations
2.28
+18.06%
1.93
+15.53%
1.67
+112.12%
0.79
Net Tangible Assets
194.10
+333.93%
44.73
+243.32%
13.03
+32.71%
9.82
Tangible Book Value
194.10
+333.93%
44.73
+243.32%
13.03
+32.71%
9.82
Current Notes Payable
—
—
0.47
+1289.48%
0.03
Duefrom Related Parties Current
0.00
-100.00%
0.03
-96.12%
0.72
0.00
Dueto Related Parties Current
4.16
0.00
—
—
Investments In Other Ventures Under Equity Method
1.33
0.00
—
—
Notes Receivable
32.01
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-37.78
-126.28%
-16.70
-208.48%
-5.41
-84.10%
-2.94
Cash Flow From Continuing Operating Activities
-37.78
-126.28%
-16.70
-208.48%
-5.41
-84.10%
-2.94
Net Income From Continuing Operations
-159.84
-392.99%
-32.42
-98.99%
-16.29
-229.50%
-4.95
Depreciation Amortization Depletion
1.91
+305.94%
0.47
+1158.25%
0.04
0.00
Depreciation
1.91
+305.94%
0.47
+1158.25%
0.04
0.00
Depreciation And Amortization
1.91
+305.94%
0.47
+1158.25%
0.04
0.00
Other Non Cash Items
1.83
-23.83%
2.41
+211.15%
0.77
+531.66%
0.12
Stock Based Compensation
16.02
+87.17%
8.56
-2.09%
8.74
+337.34%
2.00
Provisionand Write Offof Assets
0.06
0.00
—
—
Deferred Tax
-0.04
+68.53%
-0.14
-958.60%
0.02
0.00
Deferred Income Tax
-0.04
+68.53%
-0.14
-958.60%
0.02
0.00
Operating Gains Losses
—
0.04
+198.55%
-0.04
—
Unrealized Gain Loss On Investment Securities
105.91
+1411.46%
7.01
+3501.83%
0.19
+229.24%
-0.15
Net Foreign Currency Exchange Gain Loss
0.00
-100.00%
0.04
+194.07%
-0.04
0.00
Gain Loss On Sale Of PPE
0.00
-100.00%
0.00
0.00
—
Change In Working Capital
-3.63
-38.41%
-2.62
-326.09%
1.16
+3322.04%
0.03
Change In Receivables
-0.45
+10.28%
-0.51
-312.65%
0.24
0.00
Changes In Account Receivables
-0.48
+4.74%
-0.51
-312.65%
0.24
0.00
Change In Inventory
-0.32
-363.24%
-0.07
0.00
—
Change In Prepaid Assets
-2.83
-108.47%
-1.36
-148.49%
-0.55
+18.73%
-0.67
Change In Payables And Accrued Expense
1.35
+3996.97%
0.03
-94.73%
0.63
-29.60%
0.89
Change In Accrued Expense
0.57
-37.36%
0.91
+4.15%
0.87
+173.85%
0.32
Change In Payable
0.78
+189.17%
-0.88
-254.51%
-0.25
-143.36%
0.57
Change In Account Payable
0.78
+189.17%
-0.88
-290.48%
-0.22
-139.36%
0.57
Change In Other Working Capital
—
—
0.88
—
Change In Other Current Assets
1.22
+13655.56%
-0.01
+84.83%
-0.06
+59.49%
-0.15
Change In Other Current Liabilities
-2.60
-264.06%
-0.71
-3887.68%
0.02
+150.47%
-0.04
Investing Cash Flow
-110.79
-874.27%
-11.37
-363.56%
-2.45
+45.16%
-4.47
Cash Flow From Continuing Investing Activities
-110.79
-874.27%
-11.37
-363.56%
-2.45
+45.16%
-4.47
Net PPE Purchase And Sale
-9.65
+15.11%
-11.37
-387.79%
-2.33
+47.88%
-4.47
Purchase Of PPE
-9.65
+15.11%
-11.37
-387.79%
-2.33
+47.88%
-4.47
Capital Expenditure
-9.65
+15.11%
-11.37
-387.79%
-2.33
+47.88%
-4.47
Net Investment Purchase And Sale
-47.74
0.00
—
—
Purchase Of Investment
-47.74
0.00
—
—
Net Business Purchase And Sale
-23.42
0.00
+100.00%
-0.12
0.00
Purchase Of Business
-28.00
0.00
+100.00%
-0.12
0.00
Net Other Investing Changes
-29.97
—
—
—
Financing Cash Flow
371.60
+350.24%
82.53
+516.59%
13.39
+101.54%
6.64
Cash Flow From Continuing Financing Activities
371.60
+350.24%
82.53
+516.59%
13.39
+101.54%
6.64
Net Issuance Payments Of Debt
41.54
+61.49%
25.72
+14349.08%
-0.18
-1283.80%
-0.01
Issuance Of Debt
57.68
+118.17%
26.44
+4923.35%
0.53
0.00
Repayment Of Debt
-16.14
-2163.11%
-0.71
-0.88%
-0.71
-5317.85%
-0.01
Long Term Debt Issuance
57.68
+118.17%
26.44
+4923.35%
0.53
0.00
Long Term Debt Payments
-16.14
-2163.11%
-0.71
-15.17%
-0.62
-4645.52%
-0.01
Net Long Term Debt Issuance
41.54
+61.49%
25.72
+27814.45%
-0.09
-611.47%
-0.01
Short Term Debt Issuance
—
0.50
-4.82%
0.53
0.00
Short Term Debt Payments
—
-0.56
-539.79%
-0.09
0.00
Net Short Term Debt Issuance
—
-0.56
-539.79%
-0.09
0.00
Net Common Stock Issuance
320.30
+503.31%
53.09
+275.75%
14.13
+74.01%
8.12
Proceeds From Stock Option Exercised
4.92
-15.71%
5.84
0.00
—
Net Other Financing Charges
4.83
+328.13%
-2.12
-276.06%
-0.56
+61.55%
-1.47
Changes In Cash
223.03
+309.48%
54.47
+886.72%
5.52
+815.01%
-0.77
Effect Of Exchange Rate Changes
0.65
+233.68%
-0.48
-55724.68%
-0.00
-100.42%
0.21
Beginning Cash Position
61.89
+682.63%
7.91
+231.00%
2.39
-19.11%
2.95
End Cash Position
285.56
+361.40%
61.89
+682.61%
7.91
+231.01%
2.39
Free Cash Flow
-47.43
-69.00%
-28.07
-262.46%
-7.74
-4.46%
-7.41
Income Tax Paid Supplemental Data
0.08
0.00
—
—
Change In Income Tax Payable
—
0.00
+100.00%
-0.02
0.00
Change In Tax Payable
—
0.00
+100.00%
-0.02
0.00
Common Stock Issuance
320.30
+503.31%
53.09
+275.75%
14.13
+74.01%
8.12
Issuance Of Capital Stock
320.30
+503.31%
53.09
+275.75%
14.13
+74.01%
8.12
Sale Of Business
4.57
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category